Veterinary Renal Disease Market Analysis

Veterinary Renal Disease Market Analysis

To get key market trends

  Download Free Sample

The market based on type is segmented into treatment and diagnosis. The treatment segment accounted for majority of market share of 67.3% in 2023 and is expected to dominate throughout the analysis period.
 

• The segmental growth is attributed to the growing prevalence of kidney disorders in animals, that increases the demand for effective treatment options. Also, the necessity measures to manage and alleviate renal conditions in animals is on the rise with an increasing number of animals being diagnosed.
   
• Moreover, veterinarians have a wide range of tool to address several stages and kinds of renal complications in animals. Hence, the proactive and preventive healthcare highlights the significance of treatment products, thereby augmenting the segment growth.
   

The veterinary renal disease based on animal type is classified into bovine, canine, feline, equine, and other animal types. The feline animal type dominated the market and was valued at USD 6.7 billion in 2023.
 

Chronic kidney disease is a prevalent condition among aging cats, and its incidence is on the rise. This trend drives the demand for diagnostic tests, treatments, and management strategies specific to feline CKD. These factors collectively contribute to cats having the highest prevalence of veterinary renal illnesses compared to dogs, horses, and cows.
 

For instance, according to the data published by American Veterinary Medical Association in 2021, chronic kidney disease (CKD) in cats ranged between 2% - 20%. For cats older than 10 - 15 years, this number rise up to 30% - 80%. Thus, growing prevalence of CKD among cats along with increasing emphasis on early diagnosis is projected to accelerate the market growth.
 

Based on indication, the veterinary renal disease market is divided into renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, and other indications. The renal cystitis segment accounted for significant market position and is predicted to reach USD 7.5 billion by 2032.
 

• Renal cystitis is a urinary bladder inflammation which is common and recognizable indication as it occur frequently with or ahead of other renal diseases. Therefore, increasing prevalence of renal cystitis is one the major factor promoting market growth.
   
• Moreover, cystitis infection can progress to other kidney-related complications and potentially develop into pyelonephritis. Also, renal cystitis is associated with bacterial infections that ascend from the lower urinary system and impact the kidneys. Hence, the interplay of these factors collectively contributes to the expansion of this segment.
   

North America veterinary renal disease market accounted for USD 7 billion revenue in 2023 and is anticipated to grow at CAGR of 5.7% between 2024 and 2032 period.
 

• An important factor contributing to market expansion is the increasing emphasis on comprehensive animal healthcare throughout the region. As per data from the American Pet Products Association, there were 65.1 million households in the U.S. owning pets during 2023-24. Thus, adoption of pet-owning households underscores the increasing emphasis on holistic animal healthcare, serving as a significant factor propelling the market expansion in the region.
   
• Further, presence of key players, increasing R&D activities along with growing awareness pertaining to early diagnosis of renal diseases among animals will supplement the market growth.